key: cord-0884430-k8yta4s6
authors: Haribabu, Jebiti; Garisetti, Vasavi; Malekshah, Rahime Eshaghi; Srividya, Swaminathan; Gayathri, Dasararaju; Bhuvanesh, Nattamai; Mangalaraja, Ramalinga Viswanathan; Echeverria, Cesar; Karvembu, Ramasamy
title: Design and synthesis of heterocyclic azole based bioactive compounds: Molecular structures, quantum simulation, and mechanistic studies through docking as multi-target inhibitors of SARS-CoV-2 and cytotoxicity
date: 2021-10-21
journal: J Mol Struct
DOI: 10.1016/j.molstruc.2021.131782
sha: 24381c0b58d901c15475539a4059e021b1d57247
doc_id: 884430
cord_uid: k8yta4s6

Two heterocyclic azole compounds, 3-(2,3-dihydrobenzo[d]thiazol-2-yl)-4H-chromen-4-one (SVS1) and 5-(1H-indol-3-yl)-4-methyl-2,4-dihydro-3H-1,2,4-triazole-3-thione (SVS2) were obtained unexpectedly from 2-aminothiophenol and 4-oxo-4H-chromene-3-carbaldehyde (for SVS1), and (E)-2-((1H-indol-3-yl)methylene)-N-methylhydrazine-1-carbothioamide in the presence of anhydrous FeCl(3) (for SVS2), respectively. The compounds were well characterized by analytical and spectroscopic tools. The molecular structures of both the compounds were determined by single crystal X-ray diffraction (X-RD) study. The results obtained from density functional theory (DFT) study revealed the molecular geometry and electron distribution of the compounds, which were correlated well with the three-dimensional structures obtained from the single crystal X-ray diffraction. DMol(3) was used to calculate quantum chemical parameters [chemical potential (µ), global hardness (η), global softness (σ), absolute electronegativity (χ) and electrophilicity index (ω)] of SVS1 and SVS2. Molecular docking study was performed to elucidate the binding ability of SVS1 and SVS2 with SARS-CoV-2 main protease and human angiotensin-converting enzyme-2 (ACE-2) molecular targets. Interestingly, the binding efficiency of the compounds with the molecular targets was comparable with that of remdesivir (SARS-CoV-2), chloroquine and hydroxychloroquine. SVS1 showed better docking energy than SVS2. The molecular docking study was complemented by molecular dynamic simulation study of SARS-CoV-2 main protease-SVS1 complex, which further exemplified the binding ability of SVS1 with the target. In addition, SVS1, SVS2 and cisplatin were assessed for their cytotoxicity against a panel of three human cancer cells such as HepG-2 (hepatic carcinoma), T24 (bladder) and EA.hy926 (endothelial), as well as Vero (kidney epithelial cells extracted from an African green monkey) normal cells using MTT assay. The results showed that SVS2 has significant cytotoxicity against HepG-2 and EA.hy926 cells with the IC(50) values of 33.8 μM (IC(50) = 49.9 μM-cisplatin and 8.6 μM-doxorubicin) and 29.2 (IC(50) = 26.6 μM-cisplatin and 3.8 μM-doxorubicin), respectively.

Outbreak of SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) has led to more than 100 million cases and 2 million deaths as reported by WHO (World Health Organization), and these numbers are still counting. Due to this universal life threat to humans, a global response to prepare health systems is a priority [1] .

Four types of CoVs namely α, β, γ and δ were identified. Among the four, γ and δ are known to affect birds, whereas α and β affect mammals [2, 3] . The novel SARS-CoV-2 belongs to β-coronavirus lineage with four main proteins, namely, spike (S) protein (binds with bronchial epithelial cells and type-II pneumocytes after entering the host cells with the help of ACE-2 and TMPRSS2 receptors through endocytosis), membrane (M) protein (acts as an organizer of CoV assembly), envelope (E) protein (interacts with membrane protein to form an envelope) and nucleocapsid (N) protein (viral RNA genome replication) [2] . Some nucleotide analogous drugs like remdesivir and galidesivir interrupt the process of viral replication by interacting with RNAdependent RNA polymerase (RdRp), an enzyme that plays a vital role in virus replication. Some studies demonstrated that chloroquine (CQ) and hydroxychloroquine (HCQ) can reasonably inhibit SARS-CoV-2. CQ and HCQ are also suggested to block the virus entry through glycosylation of host ACE-2 receptor. Remdesivir showed inhibition activity against a variety of non-structural proteins such as RdRp [4, 5] .

To date, due to its high toxicity and the virus resistance to the drug, no effective dedicated treatments are approved for treating such CoVs. The development of new therapeutic anticorona agents made so far has also been limited [4, 5] . Heterocyclic compounds such as triazole, thiazole, pyrrole, pyridine, quinolone, etc., and their derivatives are characterized as important classes of organic compounds that exhibit various biological and medicinal properties such as antitumor [6, 7] , EGFR inhibitory [8] , antioxidant [9, 10] , antianalgesic, antiinflammatory [11] , antibacterial [12] , antifungal [13] , antimicrobial [14] , etc. The biological properties of many nitrogen based heterocyclic compounds such as triazole and its derivatives have been investigated [15] . Detailed studies have shown that they possess significant biological properties [16] [17] [18] . Demirbas et al., reported the antimicrobial activities of the triazole derivatives against several bacterial and yeast strains. The results showed that triazole derivatives are one of the active components to increase the antimicrobial activities [19] . In addition, a series of 1,2,4triazole compounds showed significant antitumoral activity, and acetylcholinesterase (AChE) 6 and human carbonic anhydrase enzymes inhibition [20] . The compounds including indole and their analogs were evaluated for their anti-hepatitis B virus (HBV), anti-inflammatory, antifungal activities, and the treatment of acute lung injury [21] [22] [23] [24] , etc. Chromones and their derivatives have played a vital role in the human diet. Many biologically active compounds derived from natural sources comprise of chromone moiety as their core [25] [26] [27] . These compounds have attracted the pharmaceutical industries to a large extent owing to their antioxidant, antitumor and antibacterial activities [28] [29] [30] . Besides these, several chromone derivatives have been used as antimicrobial, DNA binding, DNA cleavage, anticancer, anti-allergic, neuroprotective and pesticidal agents [31] [32] [33] .

Due to the existence of chromone-and heterocyclic azole-based structures in many drugs, we were motivated to synthesize such heterocyclic compounds for biological applications. In this connection, we report the synthesis of two heterocyclic compounds (SVS1 and SVS2), and the main objectives of the study are to solve the three-dimensional structures, and to explore the various pharmaceutical potentials of the compounds through in silico and in vitro studies. The compounds were characterized by single crystal X-RD, and FT-IR, UV-Visible, 1 H NMR and 13 C NMR spectroscopy. The quantum chemical parameters of the compounds were calculated by using Material studio 2017. Molecular docking studies were carried out to know their interactions with the main protease of SARS-CoV-2 and human ACE-2 receptors. The molecular docking results were further supported by molecular dynamics simulation studies. The cytotoxic potential of SVS1 and SVS2 along with the standard drugs (cisplatin and doxorubicin) was assessed using MTT assay against three cancer (HepG-2, T24 and EA.hy926) and one normal (Vero) cell lines.

Chromone-3-carboxaldehyde, 2-aminothiophenol, anhydrous FeCl 3 and solvents were purchased from commercial suppliers (Sigma Aldrich or Alfa Aesar) and used as received. (E)-2-((1H-indol-3-yl)methylene)-N-methylhydrazine-1-carbothioamide was prepared according to the previously reported procedure by us [34] [35] [36] . The melting points were measured on a Lab India instrument and are uncorrected. CHNS analyses were carried out using a Vario EL III CHNS instrument. FT-IR spectra were obtained as KBr pellets using a Ncolet-iS5 spectrophotometer. 7 UV-Visible spectra were recorded using a Shimadzu-2600 spectrophotometer. NMR spectra were recorded in DMSO-d 6 /CDCl 3 solvent using TMS as an internal standard on a Bruker 500 MHz spectrometer.

The compound was synthesized by mixing an equimolar amount of 4-oxo-4H-chromene-3-carbaldehyde (174 mg, 1 mmol) with 2-aminothiophenol (125 mg, 1 mmol) in 10 mL of ethanol, and the reaction mixture was refluxed for 4 h. The yellow color solid was filtered off from the reaction mixture, washed with cold ethanol and diethyl ether, and then dried at room temperature. The yellow block crystals of SVS1 suitable for single crystal X-RD were obtained by slow evaporation of the compound in chloroform and dimethylformamide mixture (8:2). 

(E)-2-((1H-indol-3-yl)methylene)-N-methylhydrazine-1-carbothioamide (232 mg, 1 mmol) was added to methanol (7 mL) and refluxed for 10 min. To this, 1 mmol of anhydrous Hz, 1H, aromatic-H), 3.72 (s, 1H, CH 3 ). 13 

Yellow block and brown block crystals of SVS1 and SVS2 of dimensions 0.56 × 0.54 × 0.44 mm and 0.54 × 0.21 × 0.16 mm, respectively, were chosen for the three dimensional structural studies. Single crystal X-ray diffraction (XRD) data were collected at 110 K on an APEX K  diffractometer using graphite monochromated MoK  (= 0.70173 Å) radiation. The structure was solved using XT/XS in APEX2 [37, 38] and refined by full matrix least squares on 

Material studio (DMol 3 ) software was used for optimization, and energy, HOMO (highest-occupied molecular orbital) and LUMO (lowest-unoccupied molecular orbital) calculations [40] of the compounds (SVS1 and SVS2), and remdesivir, chloroquine and hydroxychloroquine drugs (Fig. 1) . AutoDock-4.2 [41] was used for molecular docking of the compounds (SVS1, SVS2, remdesivir, chloroquine and hydroxychloroquine) at the active site of the enzymes, SARS-CoV-2 main protease and human ACE-2. For the preparation of ligands, the structures of the compounds were generated, Gasteiger charges were added, and polar hydrogen bonds were merged. These coordinates were saved in pdbqt format that contains the information about partial charges, atoms type and rotatable bonds. The 3D crystal structural coordinates of main protease of SARS-CoV-2 and human ACE-2 enzymes were retrieved from RCSB protein data bank with PDB IDs 6Y2F and 6M0J, respectively, and subjected to protein preparation (heteroatoms and water molecules were removed followed by assigning of polar hydrogen atoms and Kollman charges). The coordinates were saved in pdbqt format, and grid map for the active site was generated using Autogrid program. Docked complexes were analyzed using AutoDock tools. Active site interactions were generated using Ligplot plus [42] . 9 Molecular dynamics simulation was performed for the best pose obtained from the docking of 6Y2F and SVS1 using GROMACS version 2018.3 [43] . The protein complex was solvated using simple point-charge (SPC) water model in a cubic solvation box. The physiological pH in the protein structure was balanced by adding four sodium ions to the solvent molecules, bringing the entire system to a neutral charge. By using the steepest descent algorithm, the energy minimization was carried out for a maximum of 50000 steps. After the model structures were converged to a maximum force, a two-step equilibration via the NVT (where N is amount of substance, V is volume and T is temperature) canonical ensemble (isothermal-isochoric) equilibration was performed for 100 picoseconds (ps) at 300 K with Berendsen thermostat temperature coupling. This was followed by a constant number of particles, pressure and temperature (NPT) ensemble equilibration for another 100 ps. The LINCS (linear constraint solver) algorithm was used to constraint the covalent bonds. To treat the longrange coulombic interactions, the particle mesh Ewald (PME) method [44] was used. Production MD was carried out at a constant temperature of 300 K using the NPT ensemble for 50 ns and the MD trajectories were saved for every 10 ps. MD analysis of trajectories was done using Gromacs in-built utilities like gmx rms, rmsf, gyrate and cluster. The conformations were visualized and images were generated using Pymol [45] .

HepG-2 (hepatic carcinoma), T24 (bladder), EA.hy926 (endothelial) and Vero were seeded into the wells after dissolving them in DMSO. At the end of the incubation (24 h) of plates, the MTT dye solution (10 µL, 5 mg/mL) was added per well in dark at 37 °C for 4 h, and 100 µL of DMSO was added, and the absorbance of compounds was measured at 570 nm. IC 50 values were determined as the concentration of corresponding compound that produced a 50% reduction of cell viability [46] .

As seen in Scheme 1, 3-

was synthesized by reacting 2-aminothiophenol with 4-oxo-4H-chromene-3-carbaldehyde in [34] [35] [36] 47] 

In the FT-IR spectrum of SVS1, two bands observed at 3327 and 1608 cm -1 were assigned to ʋNH and ʋC=O, respectively (Fig. S1 ). In addition, a band appeared at 840 cm -1 due to CS stretching. The spectrum of SVS2 showed indole and triazole NH stretching frequencies at 3423 and 3219 cm -1 , respectively. Also, two bands at 1215 and 1540 cm -1 characteristic of ʋ(C=S) and ʋ(C=N) stretching frequencies, respectively, were detected [24] . The compounds showed two bands in their UV-Visible spectra corresponding to π→π * and n→π * electronic transitions in the ranges of 259-263 and 329-341 nm, respectively [22, 23] .

The NMR ( 1 H and 13 C) spectra of SVS1 and SVS2 were recorded in CDCl 3 /DMSO-d 6 solvent, and spectra are shown in Figs. S2 and S3. In the 1 H NMR spectrum of SVS1, the signals of OCH, CHNH and NH were observed at 9.29, 8.03 and 8.0 ppm, respectively. In addition, a doublet and triplet signals were seen in the region 7.99-7.47 ppm, corresponding to the aromatic protons. In the 1 H NMR spectrum of SVS2, the signals due to the NH protons (from triazole and indole) and indole CH proton appeared at 13.77 (triazole) / 11.93 (indole) and 8.08 ppm, respectively. The signals of phenyl ring protons of SVS2 were displayed at 7.99-7.17 ppm. A signal at 3.72 ppm is related to the protons of methyl group [48] .

The 13 C NMR spectra of SVS1 and SVS2 are shown in Figs. S4 and S5. The C=O carbon resonated at 174.8 ppm in the spectrum of SVS1. Moreover, the CS, CO and CNH carbons resonated at 156.5, 158.6 and 155.9 ppm, respectively. In the 13 C NMR spectrum of SVS2, a signal was observed at 185.4 ppm for carbon of C=S, while a peak related to carbon of C=N was observed at 166.7 ppm. In addition, signal of methyl carbon was observed at 32.08 ppm. The aromatic carbon signals of both the compounds were observed in their corresponding region.

Three-dimensional crystal structures of SVS1 and SVS2 were refined to good R factor of 3.6 and 2.4%, respectively. Thermal ellipsoidal plots of SVS1 and SVS2 are given in Figs. 2 and 3. All the bond lengths and angles were in the allowed ranges (Tables 1-3 ). In SVS1, O2 is planar with the ring (C1−C2−C3−C4−C5−O1) as evident from the torsion angle O2−C3−C2−C1 13 [−179.8(1)]. The five membered ring (C10−N1−C11−C12−S1) adopted twisted conformation with twist on S1−C10, and the puckering parameters are Q(2) = 0.208(1) Å and φ(2) = 205.0(4).

The molecular structure was stabilized by C−H---N intramolecular interaction which generates S(5) pattern (Fig. 4, Table 4 ). Crystal packing was stabilized by N−H1---O2 (x, -y+3/2, z+1/2) intermolecular hydrogen bond, generating chain C(6) (Fig. 4) . As compound SVS2 crystallized in non-centrosymmetric space group P2 1 2 1 2 1 , the absolute structure was relevant and the Flack parameter, x [0.046 (16) 1)] indicated that C11 and S1 were almost in-plane with a five membered ring to which they were attached. The molecular structure of SVS2 was stabilized by C−H---S intramolecular interaction, generating S(5) pattern (Fig. 4b) . The crystal packing was stabilized by N−H---S and N−H---N intermolecular hydrogen bonds. Atoms N1 and N3 in the molecule at x, y, z act as donors to atoms S1 and N2 at -x+1, y-1/2, -z+1/2 and x-1/2, -y+3/2, -z+1, generating C(8) and C(3) chains, respectively (Fig. 4b) .

We optimized the compounds to obtain energies, HOMO and LUMO in Materials studio software. SVS1, SVS2 and the drugs (chloroquine, hydroxychloroquine and remdesivir) were optimized and are shown in 

The module DMol3 in Materials studio 2017 was used to calculate quantum chemical parameters such as chemical potential (µ), global hardness (η), global softness (σ), absolute electronegativity (χ) and electrophilicity index (ω) for the studied compounds [49].

To describe the chemical and biological reactivity ranking of SVS1 and SVS2, various electronic parameters such as ionization potential (I), electron affinity (A), absolute electronegativity (χ) and chemical hardness (η) were calculated. I and A were calculated as the negative of energy values of HOMO and LUMO, respectively ( Table 5 ).

The chemical reactivity of molecules increased with the increasing of I. Systems having high E HOMO such as DNA are good electron donors, and drugs or synthesized compounds having 15 low E LUMO are good electron acceptors [50] . So, with more negative E LUMO , chemical reactivity of molecules increased as electron acceptor. The electron affinity value (A) of SVS2 )0.0735 eV( was lower than that of SVS1 )0.1080 eV(. So, SVS2 may be able to interact with the targeted biomolecules (DNA or protein) better than SVS1 due to more negative E LUMO [6] . The band gap is an important parameter to determine some of the molecular properties such as global hardness (η), electronegativity (χ), chemical potential (µ) and global electrophilicity index (ω) ( Table 4 ).

If energy gap is decreased, it leads to less stability, high kinetic energy, high chemical reactivity and more polarization [51] . The hardness (η) of the compounds was calculated using Eq. 1 and values are given in Table 5 [40] . 

Chemical potential (µ) can be associated with the electron withdrawing capability [51] .

The values of chemical potential (µ) of SVS1 and SVS2 were 1.5664 and 1.8860 eV, respectively. As a result, SVS2 had more chemical potential (µ) and electronegativity (χ) than SVS1 [3, 51] . In addition, chemical potential (µ) is associated to the adsorptive capacity. An elevated value of chemical potential showed enhanced adsorption between molecules and biological systems as well as the adsorbent surfaces. Therefore, the high value of chemical potential can cause electron transfer from a molecule to biological systems. As a result, electrons of SVS2 can be transferred easily to the biological systems. 16 The electrophilicity index (ω) can be calculated using the chemical potential and chemical hardness (Eq. 2) [52, 53] .

The electron accepting ability of a molecule from the surrounding without changing its stability is referred to electrophilicity index (ω) [51] . In addition, the toxicity of compounds such as antimicrobial, anticancer etc. can be estimated through electrophilicity index (ω) [54] . A compound with a low electrophilicity index is anticipated to have less toxicity [55] . The electrophilicity index (ω) values for SVS1 and SVS2 were 23.7752 and 30.1440 eV, respectively (Table 5 ). The higher value of electrophilicity index (ω) for SVS2 can be correlated with its less toxicity. So, low concentration of SVS2 is enough to kill cancer cells [29, 30] . inhibitors for the treatment of lung inflammation and necrosis [32, 34] .

In our study, the synthesized heterocyclic compounds (SVS1 and SVS2) were screened against the SARS-CoV-2 main protease (M pro ) enzyme and human ACE-2 receptor through molecular docking. The structures of our compounds are similar to some commercially available drugs containing thiazole, 1,3,4-oxadiazole and heterocyclic moieties (Fig. 7) . Amongst the coronavirus targets, the main protease (M pro ) has received a major attention [58, 59] , and ACE-2 plays a critical role for SARS-CoV to enter into target cells. So, ACE-2 is also one of the key targets for therapeutic development [36, 37] The gmx cluster command was used to form clusters based on the RMSD over the entire 50 ns time frame, and a representative of the largest cluster was taken as the average complex structure. It was observed the ligand SVS1 is found to interact in the active site pocket of the enzyme both in the initial pose and also in the average complex structure. This indicates that the ligand SVS1 has not deviated much from the active site pocket and has been quite stable in the active site throughout the 50 ns MDS. Fig. 11(a) shows the cavity of binding site with SVS1

from the initial pose in red and from the average representative structure of the MD run in blue.

On superimposing the initial and average representative structures, an RMSD of 1.8 Å was calculated and the image can be seen in Fig. 11(b) . These results highlight the stability of SVS1

at the active site of the enzyme throughout the simulation, and it maintained the dynamic interactions at the active site of the SARS-CoV-2 main protease. and cisplatin (Table 7) , it was found that SVS1 and SVS2 were more active against T24 cells than cisplatin. Further, the cytotoxicity of SVS1 was more than that of SVS2 against T24 cells.

In addition, both SVS2 and cisplatin were highly toxic against EA.hy926 cancer cells. To explore the selectivity, the cytotoxicity of SVS1, SVS2 and cisplatin was investigated in Vero normal cells. The IC 50 values of SVS1, SVS2, cisplatin and doxorubicin against Vero normal cells were >100, >100, 29.5 and 8.9 µM, respectively ( Table 7 ). It appears as SVS1 and SVS2

were selective to cancer cell lines, and hence these can be tested as chemotherapeutic drugs.

SVS1 was prepared from 2-aminothiophenol and 4-oxo-4H-chromene-3-carbaldehyde. showed that the chemical reactivity of SVS1 was more than that of SVS2. As a result, the hardness of SVS1 was lower than that of SVS2. In addition, SVS2 had high stability and polarization. The electrons of SVS2 might be able to be transferred to the biological systems rather than those of SVS1 due to the high chemical potential of SVS2.

SVS2 possessed a high value of electrophilicity index (ω) compared to SVS1, which can be correlated with its high toxicity. Hence, SVS2 can act as a better cytotoxic compound even at low concentrations. Based on quantum calculations, SVS2 as electron acceptor, was more reactive when compared with SVS1 due to its more negative E LUMO . Binding energies of the compounds with the target enzymes based on the molecular docking results clearly showed that SVS1 had more binding potential than SVS2. The active site interactions of SVS1 and SVS2

were comparable with remdesivir, chloroquine and hydroxychloroquine. Molecular dynamics simulation of M pro -SVS1 complex clearly showed the stability of SVS1 to interact only at the active site of the enzyme. At last, the study was complemented by the cytotoxic activity of 20 compounds against three human cancer (HepG-2, T24 and EA.hy926) and one normal (Vero) cells. SVS2 was more active than the other compounds against liver (HepG-2) cancer cells. In addition, SVS1 and SVS2 were more active against T24-bladder cancer cells than cisplatin.

Furthermore, it was found that SVS2 and cisplatin had a higher cytotoxic activity than SVS1

against EAhy926 cancer cells. The IC 50 values of SVS1, SVS2 and cisplatin against Vero normal cells showed that SVS1 and SVS2 were selectively toxic against the cancer cells. The mode of cell death and in vitro cytotoxicity will be analyzed to further establish its therapeutic potential as anticancer/antiviral agent. 

☒ The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

☐ The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:

The authors declare no competing financial interest. Table 2 Selected geometric parameters (Å, ).

Selected torsion angles ().

Torsion angle (°) SVS2 

COVID-19 in Brazil: Evolution of the epidemic up until epidemiological week 20 of 2020

Synthesis of palladium(II) complexes via Michael addition: Antiproliferative effects through ROS-mediated mitochondrial apoptosis and docking with SARS-CoV-2

Azafluorene derivatives as inhibitors of SARS CoV-2 RdRp: Synthesis, physicochemical, quantum chemical, modeling and molecular docking analysis

Ovo delivered toll-like receptor 7 ligand, resiquimod enhances host responses against infectious bronchitis corona virus (IBV) infection, Vaccines

Peptide-like and small-molecule inhibitors against Covid-19

Synthesis, spectral (FT-IR, UV-visible, NMR) features, biological activity prediction and theoretical studies of 4-amino-3-(4-hydroxybenzyl)-1H-1,2,4-triazole-5(4H)-thione and its tautomer

6-Sulfonylbenzothiazolones as potential scaffolds for the design of 5-HT6 ligands

Abdel-Rahman, Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors

Synthesis, crystal structure, and in vitro and in silico molecular docking of novel acyl thiourea derivatives

Isatin based thiosemicarbazone derivatives as potential bioactive agents: Anti-oxidant and molecular docking studies

Synthesis of 5-(2-,3-and 4-methoxyphenyl)-4H-1,2,4-triazole-3-thiol derivatives exhibiting anti-inflammatory activity

Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drugresistant bacteria

Triazolothiadizepinylquinolines as potential MetAP-2 and NMT inhibitors: Microwaveassisted synthesis, pharmacological evaluation and molecular docking studies

1-Acylthiosemicarbazides, 1,2,4-triazole-5(4H)-thiones, 1,3,4-thiadiazoles and hydrazones containing 5-methyl-2-benzoxazolinones: Synthesis, analgesic-antiinflammatory and antimicrobial activities

Studies on the anticonvulsant activity of 4-alkyl-1,2,4-triazole-3-thiones and their effect on GABAergic system

Effect of N-(m-bromoanilinomethyl)-p-isopropoxyphenylsuccinimide on the anticonvulsant action of four classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model

Synthesis and bioactivities of novel thioether/sulfone derivatives containing 1,2,3-thiadiazole and 1,3,4-oxadiazole/thiadiazole moiety

Synthesis of some new 1,3,4-thiadiazol-2-ylmethyl-1,2,4-triazole derivatives and investigation of their antimicrobial activities

In vitro cytotoxic and in vivo antitumoral activities of some aminomethyl derivatives of 2,4-dihydro-3H-1,2,4-triazole-3-thiones -Evaluation of their acetylcholinesterase and carbonic anhydrase enzymes inhibition profiles

Base promoted synthesis of novel indole-dithiocarbamate compounds as potential anti-inflammatory therapeutic agents for treatment of acute lung injury

Synthesis and structure-antituberculosis activity relationship of 1H-indole-2,3-dione derivatives

Synthesis and antifungal activity of 1H-indole-4,7-diones

Design, synthesis, biological evaluation, and molecular docking of 1,7-dibenzyl-substituted theophylline derivatives as novel BRD4-BD1-selective inhibitors

Synthesis, anticancer and antioxidant activities of 7-methoxyisoflavanone and 2,3-diarylchromanones

Unprecedented formation of palladium(II)-pyrazole based thiourea from chromone thiosemicarbazone and

A model β-sheet interaction and thermodynamic analysis of β-strand mimetics

One-pot reaction of ortho-acylphenols and terminal alkynoates for synthesis of 2-alkyl-substituted chromanones

NHC-catalyzed green synthesis of functionalized chromones: DFT mechanistic insights and in vitro activities in cancer cells

Discovery of new chemical entities for old targets: Insights on the lead optimization of chromone-based monoamine oxidase B (MAO-B) inhibitors

In vivo antitumor, in vitro antibacterial activity and alkylating properties of phosphorohydrazine derivatives of coumarin and chromone

Identification of a chromone-based retinoid containing a polyolefinic side chain via facile synthetic routes

The synthesis and anticancer activities of chiral epoxy-substituted chromone analogs

Water-soluble mono-and binuclear u(η 6 -p-cymene) complexes containing indole thiosemicarbazones: Synthesis, DFT modeling, biomolecular interactions, and in vitro anticancer activity through apoptosis

Zinc(II) complexes of indole thiosemicarbazones: DNA/protein binding, molecular docking and in vitro cytotoxicity studies

Synthesis of Ni(II) complexes bearing indole-based thiosemicarbazone ligands for interaction with biomolecules and some biological applications

A short history of SHELX

Crystal structure refinement with SHELXL

Olex2: A complete structure solution, refinement and analysis program

Molecular dynamics simulation of novel diaminofunctionalized hollow mesosilica spheres for adsorption of dyes from synthetic waste water

AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery

GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers

Accuracy and efficiency of the particle mesh Ewald method

N-substitution in isatin thiosemicarbazones decides nuclearity of Cu(II) complexes -Spectroscopic , molecular docking and cytotoxic studies

Synthesis, structures and mechanistic pathways of anticancer activity of palladium(II) complexes with indole-3-carbaldehyde thiosemicarbazones

Nickel(II) bis(isatin thiosemicarbazone) complexes induced apoptosis through mitochondrial signaling pathway and G0/G1 cell cycle arrest in IM-9 cells

Molecular dynamic simulation and DFT computational studies on the adsorption performances of methylene blue in aqueous solutions by orange peel-modified phosphoric acid

Synthesis, structure and DNA binding properties of a homodinuclear Cu(II) complex: An experimental and theoretical approach

Synthesis, physicochemical and quantum chemical studies on a new organic NLO crystal: Cinnamoylproline

Schiff base clubbed benzothiazole: Synthesis, potent antimicrobial and MCF-7 anticancer activity, DNA cleavage and computational study

Abrahams, Synthesis, characterisation and anticancer activity screening of lanthanide(III) acetate complexes with benzohydrazone and nicotinohydrazone ligands

A cytotoxicity, optical spectroscopy and computational binding analysis of 4-[3-acetyl-5-(acetylamino)-2-methyl-2,3-dihydro-1,3,4-thiadiazole-2-yl]phenyl benzoate in calf thymus DNA

COVID-19: Therapeutic approaches description and discussion

Quinazoline-Schiff base conjugates: In silico study and ADMET predictions as multi-target inhibitors of coronavirus (SARS-CoV-2) proteins

Several coumarin derivatives and their Pd(II) complexes as potential inhibitors of the main protease of SARS-CoV-2, an in silico approach

The SARS-CoV-2 main protease as drug target

Towards a facile and convenient synthesis of highly functionalized indole derivatives based on multi-component reactions

Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms

Synthesis and biological evaluation of novel N-(piperazin-1-yl)alkyl-1H-dibenzo[a,c]carbazole derivatives of dehydroabietic acid as potential MEK inhibitors

Chemistry of 1,2,4-triazole: A review article

Bond length (Å)/angle (°) SVS1 Bond length (Å)/angle (°)

)−N(3)−C(10)−N

C(11)−N(4)−C(10)−S(1)

N(4)−C(10)−N(3) −176